Renee Parker

Title: The Innovative Contributions of Inventor Renee Parker

Introduction

Renee Parker is a notable inventor based in Woodbury, MN (US). She has made significant contributions to veterinary diagnostics, particularly in the detection of hemangiosarcoma in canines. With a total of 2 patents, her work has the potential to improve the health and well-being of dogs diagnosed with this serious condition.

Latest Patents

Renee Parker's latest patents focus on a method for diagnosing hemangiosarcoma in canines through the detection of thymidine kinase activity. The method involves several steps: first, obtaining a quantity of blood from the subject canine; second, separating the blood into a serum portion and a non-serum portion; third, contacting the serum portion with a detector to identify the presence of thymidine kinase (TK); and finally, detecting the level of TK in serum to determine if it is present in amounts of about 8 units/L or greater. This innovative approach provides a crucial tool for veterinarians in diagnosing this life-threatening condition.

Career Highlights

Throughout her career, Renee Parker has worked with esteemed organizations such as the Veterinary Diagnostics Institute, Inc. and the Colorado State University Research Foundation. Her experience in these institutions has allowed her to develop and refine her diagnostic methods, contributing to advancements in veterinary medicine.

Collaborations

Renee has collaborated with notable colleagues, including Randy Ringold and Douglas Thamm. These partnerships have fostered an environment of innovation and shared knowledge, further enhancing her contributions to the field.

Conclusion

Renee Parker's work in veterinary diagnostics exemplifies the impact of innovative thinking in addressing critical health issues in animals. Her patents and collaborations highlight her commitment to improving canine health through scientific advancements.